Syndax Pharmaceuticals Correlations

SNDX Stock

USD 15.57 0.33 2.17%

The current 90-days correlation between Syndax Pharmaceuticals and Cogent Biosciences is 0.16 (i.e., Average diversification). The correlation of Syndax Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Syndax Pharmaceuticals Correlation With Market

Average diversification

The correlation between Syndax Pharmaceuticals and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Syndax Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.

Moving together with Syndax Stock

0.61	RYTM	Rhythm Pharmaceuticals	Pair Corr
0.78	ANAB	AnaptysBio	Pair Corr
0.67	STRO	Sutro Biopharma	Pair Corr
0.77	CRSP	Crispr Therapeutics	Pair Corr

Moving against Syndax Stock

0.76	NAMSW	NewAmsterdam Pharma Upward Rally	Pair Corr
0.69	XFOR	X4 Pharmaceuticals	Pair Corr
0.41	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.31	DRMA	Dermata Therapeutics	Pair Corr
0.72	CGTX	Cognition Therapeutics	Pair Corr
0.54	BNTC	Benitec Biopharma	Pair Corr
0.46	EMBC	Embecta Corp	Pair Corr
0.63	PTITF	PT Indosat Tbk	Pair Corr
0.56	ADUS	Addus HomeCare	Pair Corr
0.41	SSNLF	Samsung Electronics	Pair Corr

Related Correlations Analysis

	COGT	CGEM	KALV	MRSN	PLRX	RVMD	VRDN	INZY	AVTE	KROS
COGT		0.42	0.41	0.39	0.31	0.56	0.56	0.04	0.41	0.62	COGT
CGEM	0.42		0.02	0.87	0.8	0.74	0.82	0.85	0.79	0.75	CGEM
KALV	0.41	0.02		0.21	-0.31	0.4	0.02	-0.07	-0.08	0.4	KALV
MRSN	0.39	0.87	0.21		0.67	0.74	0.65	0.85	0.59	0.85	MRSN
PLRX	0.31	0.8	-0.31	0.67		0.43	0.76	0.72	0.78	0.49	PLRX
RVMD	0.56	0.74	0.4	0.74	0.43		0.67	0.57	0.54	0.81	RVMD
VRDN	0.56	0.82	0.02	0.65	0.76	0.67		0.65	0.82	0.55	VRDN
INZY	0.04	0.85	-0.07	0.85	0.72	0.57	0.65		0.64	0.54	INZY
AVTE	0.41	0.79	-0.08	0.59	0.78	0.54	0.82	0.64		0.49	AVTE
KROS	0.62	0.75	0.4	0.85	0.49	0.81	0.55	0.54	0.49		KROS
	COGT	CGEM	KALV	MRSN	PLRX	RVMD	VRDN	INZY	AVTE	KROS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MRSN	+ 0.87	CGEM
INZY	+ 0.85	CGEM
INZY	+ 0.85	MRSN
KROS	+ 0.85	MRSN
VRDN	+ 0.82	CGEM
AVTE	+ 0.82	VRDN

High negative correlations

PLRX	- 0.31	KALV
AVTE	- 0.08	KALV
INZY	- 0.07	KALV

Risk-Adjusted Indicators

There is a big difference between Syndax Stock performing well and Syndax Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Syndax Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
COGT	2.55	(0.34)	0.00	(0.23)	0.00	0.00	5.43	(6.30)	18.81
CGEM	2.48	(0.65)	0.00	(1.68)	0.00	0.00	4.98	(6.27)	15.27
KALV	2.85	0.18	0.06	0.89	3.13	(3.14)	6.22	(4.79)	15.24
MRSN	5.97	(1.64)	0.00	(1.11)	0.00	0.00	9.05	(13.89)	53.67
PLRX	4.91	(1.34)	0.00	(1.09)	0.00	0.00	10.38	(8.16)	72.98
RVMD	1.72	(0.39)	0.00	(0.53)	0.00	0.00	2.10	(5.94)	14.57
VRDN	2.70	(0.35)	0.00	(0.43)	0.00	0.00	4.19	(5.12)	29.75
INZY	4.08	(1.20)	0.00	0.79	0.00	0.00	7.72	(8.61)	38.13
AVTE	1.45	(0.07)	0.00	(0.19)	0.00	0.00	4.30	(3.27)	10.45
KROS	4.16	(1.46)	0.00	(2.61)	0.00	0.00	5.53	(7.31)	82.94

Syndax Pharmaceuticals Corporate Management

Briggs MD	Head Pres	Profile
Steven Closter	Chief Officer	Profile
Michael MBA	CEO Director	Profile
Steve Sabus	Chief Officer	Profile
Joseph MD	Member Officer	Profile
Ronald Evans	Advisor CoFounder	Profile
Sharon Klahre	Vice Communications	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC